Literature DB >> 18331230

RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease.

Heikki Rauvala1, Ari Rouhiainen.   

Abstract

HMGB1/Amphoterin is a ubiquitous, highly conserved DNA-binding protein that can be also released to the extracellular space by various cell types. Extracellular HMGB1 regulates migratory responses of several cell types through binding to RAGE that communicates with the cytoskeleton to regulate cell motility. HMGB1-induced cell signalling has been associated with mechanisms of several diseases, including cancer, sepsis, rheumatoid arthritis, stroke and atherosclerosis. This article reviews the evidence linking the functional roles of HMGB1 to RAGE signalling. Furthermore, we discuss the molecular and cellular mechanisms that may explain the roles of HMGB1/RAGE in diverse disease processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18331230     DOI: 10.2174/156652407783220750

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  37 in total

1.  Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.

Authors:  Te I Weng; Hsiao Yi Wu; Chia Wei Kuo; Shing Hwa Liu
Journal:  Intensive Care Med       Date:  2011-01-29       Impact factor: 17.440

2.  HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation.

Authors:  Elia Ranzato; Mauro Patrone; Marco Pedrazzi; Bruno Burlando
Journal:  Mol Cell Biochem       Date:  2009-07-09       Impact factor: 3.396

3.  S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.

Authors:  Roberta Bianchi; Eirini Kastrisianaki; Ileana Giambanco; Rosario Donato
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 4.  High-mobility group box 1, oxidative stress, and disease.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Antioxid Redox Signal       Date:  2011-04-01       Impact factor: 8.401

Review 5.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

6.  High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.

Authors:  Margaret A Baumbusch; Catalin S Buhimschi; Emily A Oliver; Guomao Zhao; Stephen Thung; Kara Rood; Irina A Buhimschi
Journal:  Cytokine       Date:  2016-03-05       Impact factor: 3.861

Review 7.  RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?

Authors:  Shi Du Yan; Angelika Bierhaus; Peter P Nawroth; David M Stern
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

9.  Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.

Authors:  Catalin S Buhimschi; Margaret A Baumbusch; Antonette T Dulay; Emily A Oliver; Sarah Lee; Guomao Zhao; Vineet Bhandari; Richard A Ehrenkranz; Carl P Weiner; Joseph A Madri; Irina A Buhimschi
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

Review 10.  High-mobility group protein box-1 and its relevance to cerebral ischemia.

Authors:  Qing-wu Yang; Jing-Zhou Wang; Jing-Cheng Li; Yu Zhou; Qi Zhong; Feng-Lin Lu; Jing Xiang
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.